from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1923/lipD

LFCtreatmentdescriptionclass of inhibitor

-1.119

Amikacinug/mL Amikacintranslation

0.309

Cap5-10ug/mL Capreomycintranslation

-0.855

Rox10-50 ug/mL Roxithromycintranslation

0.481

SM2-5 ug/mL Streptomycintranslation

-2.003

Tet5-10 ug/mL Tetracyclinetranslation

0.009

Rif0.2-5ug/mL Rifampicintranscription

-0.283

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.645

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.475

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.923

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.719

Clofazimine10-13 ug/mL Clofaziminerespiration

0.335

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.172

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.398

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.366

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.252

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.027

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.503

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.440

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.403

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.462

KCN5-20 ug/mL Potassium cyaniderespiration

1.434

NaN30.2-2 mM Sodium aziderespiration

1.481

Nigericin50 uM Nigericinrespiration

-0.041

TRC10-150 ug/mL Triclosanrespiration

-1.044

TRZ10-25 ug/mL Thioridazinerespiration

-2.574

Valinomycin0.5-10 uM Valinomycinrespiration

0.765

ZnSO42 mM ZnSO4respiration

0.177

menadione6-10 ug/mL Menadionerespiration

-0.304

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.347

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.077

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.215

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.460

NRP_1Non-replicating persistence stage 1dosRassociated

0.219

Amp0.2mg/mL AmpicillincellWall

-0.324

Cephalexin20-100 ug/mL CephalexincellWall

0.094

Cerulenin0.32-5 ug/mL CerulenincellWall

0.176

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.172

EMB10-20 ug/mL EthambutolcellWall

0.385

Eta12-40 ug/mL EthionamidecellWall

0.620

INH0.2-0.4 ug/mL IsoniazidcellWall

0.617

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.056

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.081

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.041

BZA0.12 mg/mL BenzamidearomaticAmides

0.120

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.105

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.152

H2O24 mM hydrogen peroxideDNAdamaging

0.383

Levo10 ug/mL LevofloxacinDNAdamaging

0.098

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.373

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.603

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.151

UVUV-irradiationDNAdamaging

-2.115

ARP41-4 ug/mL Antitubercular compound ARP4?

0.718

Antimycin12.5-50 ug/mL Antimycin A?

-0.137

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.569

PA_110-50 ug/mL Antitubercular compound PA-1?

1.097

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.468

PA8240.2-2 ug/mL PA-824?

0.336

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.535

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.991

Verapamil50 uM Verapamil?

-0.129

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.147

methoxatin10-20 ug/mL Methoxatin?